The Epidemiology Change From 2006 to 2022 of Infective Endocarditis in Taiwan
1 other identifier
observational
2,247
1 country
1
Brief Summary
Infective endocarditis has long been one of the significant diseases causing death and disability worldwide. Its incidence has shown an increasing trend over the past few decades. Moreover, there seems to be significant variation in prevalence and epidemiology in different geographic regions and countries. This study aims to understand the trends and changes in the epidemiology of infective endocarditis in Taiwan from the 2006s to the present. Through a retrospective database analysis using the "Taiwan Healthcare System Integration Database," the goal is to improve the prognosis of infective endocarditis treatment in Taiwan.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 8, 2023
CompletedFirst Submitted
Initial submission to the registry
April 28, 2025
CompletedFirst Posted
Study publicly available on registry
September 5, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedSeptember 5, 2025
April 1, 2025
2.1 years
April 28, 2025
September 1, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Recent epidemiological trends and changes in infective endocarditis in Taiwan over the past decades
2006 to 2022
Interventions
Observational study, not interventional
Eligibility Criteria
Patients who were discharged from hospital or received an emergency diagnosis of infective endocarditis between January 1, 2006 and December 31, 2022
You may qualify if:
- Patients who were discharged from hospital or received an emergency diagnosis of infective endocarditis between January 1, 2006 and December 31, 2022
You may not qualify if:
- Patients without infective endocarditis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
NTUH
Taipei, Taiwan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- WANG-HUEI SHENG
Study Record Dates
First Submitted
April 28, 2025
First Posted
September 5, 2025
Study Start
November 8, 2023
Primary Completion
December 31, 2025
Study Completion
December 31, 2025
Last Updated
September 5, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
local epidemiology in order